Types of ArticlesDNA Repair provides a forum
for the comprehensive coverage of cellular responses to DNA damage in living cells. The journal publishes original observations on genetic,
cellular, biochemical and molecular aspects of DNA repair, mutagenesis, cell cycle regulation, apoptosis and other biological responses
to cells exposed to genomic insult, as well as their relationship to human diseases. DNA Repair publishes Full-length research
papers, Brief Report of Research, Invited minireviews, Letters to the Editor, Hot Topics in DNA repair, Classics in DNA repair, Historical
reflections, Book reviews and Meeting Reports. DNA Repair also welcomes Correspondence from the scientific community, especially
as they relate to papers previously published in the journal. These are handled directly by the Editor-in-Chief and may be accompanied
by responses solicited papers are published monthly. In addition, the journal will publish a smaller number of peer-reviewed Brief Reports
on original research findings of special interest, as well as invited Mini-reviews on selected topics that provide 'state-of-the-art'
synopses of cellular responses to DNA damage. Book reviews and meeting reports will be regularly featured and the Journal welcomes Correspondence
from the scientific community, especially as they relate to papers previously published in the journal. These are handled directly by
the Editor-in-Chief and may be accompanied by responses solicited from relevant individuals.
On-line Submission. Submission
to this journal proceeds totally on-line. Via the homepage of this journal (http://www.elsevier.com/locate/dnarep) you will
be guided stepwise through the creation and uploading of the various files. The system automatically converts source files to a single
Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files
are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All
correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail, removing the need for
a hard-copy paper trail.
Submission of a manuscript will be held to imply that it contains original work and that it has not
been published or submitted for publication elsewhere. It also implies the transfer of the Copyright from the author to the publisher.
Conflict of interest. DNA Repair requires full disclosure of all potential conflicts of interest. At the end of
the manuscript text (and in the cover letter of the manuscript), under a subheading "Conflict of Interest statement", all authors must
disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their
work. If there are no conflicts of interest, the authors should state, "The authors declare that there are no conflicts of interest."
Signed copies of the DNA Repair Conflict of Interest policy form are required upon submission. The Conflict of Interest policy
form can be downloaded here. In order to minimize delays,
we strongly advise that the signed copies of these statements are prepared before you submit your manuscript. The corresponding author
is responsible for sharing this document with all co-authors. Each and every co-author must sign an individual disclosure form. The corresponding
author is responsible for uploading their form and those of their co-authors.
General arrangement of papers. Papers should
be in English, typewritten, and double-spaced. Final versions should be accompanied by a diskette (see `Electronic manuscripts' below).
They should include key words (3-6 words or short phrases) and an abstract of up to 300 words. The Introduction should
summarize the research problem and the pertinent findings. The text may be divided into sections such as Materials and methods, Results,
Discussion, etc. All main sections should be numbered. In papers mentioning chemicals, authors are requested to include CAS registry
numbers.
Preparation of text. Each manuscript should have a separate title page which includes only the title, authors'
full names and complete addresses of academic of professional affiliations; the author to whom proofs and correspondence should be addressed
should be indicated by an asterisk and a telephone/fax number and e-mail address included.
Colour
illustrations. Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct
resolution. Polaroid prints are not suitable. If, together with your accepted article, you submit usable colour figures then Elsevier
will ensure, at no additional charge, that these figures will appear in colour on the Web (e.g. Science Direct and other sites) regardless
of whether or not these illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive
information regarding the costs from Elsevier after receipt of your accepted article. Reproduction of colour figures in review articles
and in special issues is free of charge.
Please note: Because of technical complications which can arise by converting colour figures
to "grey scale" (for the printed version should you not opt for paid colour in print) please submit in addition usable black and white
versions of your colour illustrations.
Tables should be typed with double line spacing and should have a heading.
References.
Only papers using the numbered reference system will be accepted, i.e. references are numbered by order of citation in the text. Journal
titles should be abbreviated to conform with the Chemical Abstracts Bibliographic Guide for Authors and Editors 1974.
Examples:
[1] B.N. Ames, J. McCann, E. Yamasaki. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity
test, Mutation Res. 31 (1975) 347-363.
[2] L. Ehrenberg, C.A. Wachtmeister. Safety precautions in work with mutagenic and carcinogenic
chemicals, in: B.J. Kilbey, M.S. Legator, W. Nichols and C. Ramel (Eds.), Handbook of Mutagenicity Test Procedures, Elsevier, Amsterdam,
1977, pp. 401-410.
Nomenclature. Authors are requested to adopt the nomenclature system for human gene mutations recommended
by the HUGO MDI Nomenclature Working Group. Guidelines for this system can be found at http://journals.wiley.com/1059-7794/nomenclature.html.
Language Editing. International Science Editing and Asia Science Editing can provide English language and copyediting services
to authors who want to publish in scientific, technical and medical journals and need assistance before they submit their article or,
before it is accepted for publication. Authors can contact these services directly: International Science Editing (http://www.internationalscienceediting.com)
and Asia Science Editing (http://www.asiascienceediting.com) or, for more information about language editing services, please
contact authorsupport@elsevier.com who will be happy to deal with any questions.
Proofs. When a manuscript is received by
the Publisher it is considered to be in its final form. Proofs are automatically sent to the corresponding author. Only printer's errors
may be corrected, no changes in or additions to the edited manuscript will be accepted. To return corrected proofs by courier service,
please send to: Log-in Department, DNA Repair, Elsevier Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co.
Clare, Ireland.
Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible.
Therefore, it is important to ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will
not be possible, so please ensure your first sending is complete.
Offprints. The corresponding author, at no cost, will be
provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file is a watermarked version
of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions
of use.
Author enquiries. For enquiries relating to the submission of articles, please visit the journal homepage at http://www.elsevier.com/locate/dnarep.
The journal homepage also provides the facility to track accepted articles and to set-up e-mail alerts to inform you when the status
of your article has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more.
All questions arising after acceptance of a manuscript, especially those relating to proofs, publication and reprints, should be directed
to the publishers, Martina Canavan at Elsevier Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland;
Tel.: +353 61 709610; Email: m.canavan@elsevier.ie
US National Institutes of Health (NIH) voluntary posting ("Public
Access") policy.
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH "Public Access
Policy"; see http://www.nih.gov/about/publicaccess/index.htm)
by posting the peer-reviewed author?s manuscript directly to PubMed Central on request from the author, 12 months after formal publication.
Upon notification from Elsevier of acceptance, we will ask you to confirm via e-mail (by e-mailing us at NIHauthorrequest@elsevier.com)
that your work has received NIH funding and that you intend to respond to the NIH policy request, along with your NIH award number to
facilitate processing. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version of your manuscript that
will include peer-review comments, for posting 12 months after formal publication. This will ensure that you will have responded fully
to the NIH request policy. There will be no need for you to post your manuscript directly with PubMed Central, and any such posting is
prohibited.
